Table 2.
Baseline and absolute mean change (SD) from baseline by treatment groups for sway index.
| SWAYEOFI | SWAYECFI | SWAYEOFO | SWAYECFO | ||
|---|---|---|---|---|---|
| Baseline | 400 IU | 0.4 (0.1) | 0.7 (0.2) | 0.7 (0.2) | 2.2 (0.4) |
| 4000 IU | 0.4 (0.1) | 0.7 (0.2) | 0.7 (0.2) | 2.2 (0.5) | |
| 10,000 IU | 0.4 (0.1) | 0.7 (0.2) | 0.7 (0.2) | 2.2 (0.5) | |
| Δ 12-month | 400 IU | 0.00 (0.1) | 0.00 (0.2) | −0.02 (0.1) | −0.10 (0.3) ad |
| 4000 IU | 0.01 (0.1) | −0.01 (0.2) | −0.01 (0.2) | −0.11 (0.4) ad | |
| 10,000 IU | 0.00 (0.1) | 0.01 (0.2) | −0.02 (0.2) | −0.11 (0.4) ad | |
| Δ 24-month | 400 IU | −0.02 (0.1) | 0.00 (0.2) | −0.03 (0.2) a | −0.14 (0.3) a |
| 4000 IU | 0.00 (0.1) | 0.01 (0.2) | −0.02 (0.1) a | −0.14 (0.4) a | |
| 10,000 IU | −0.01 (0.1) | 0.00 (0.2) | −0.05 (0.1) a | −0.18 (0.4) a | |
| Δ 36-month | 400 IU | −0.01 (0.1) | 0.02 (0.2) | −0.03 (0.2) a | −0.19 (0.4) ab |
| 4000 IU | 0.01 (0.1) | 0.00 (0.2) | −0.03 (0.1) a | −0.16 (0.4) ab | |
| 10,000 IU | 0.00 (0.1) | 0.01 (0.2) | −0.04 (0.1) a | −0.21 (0.4) ab |
EOFI = eyes open firm surface, ECFI = eyes closed firm surface, = EOFO eyes open foam surface and ECFO = eyes closed foam surface. p < 0.05 (with Bonferroni adjustment) were significantly different from a baseline, b 12 months, c 24 months and d 36 months.